摘要
目的 本文就氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的应用效果进行探讨.方法 选择本院近一年收治的88例高血压合并冠心病患者,按照抽签法分为实验组(n=44)与参照组(n=44),实验组患者采用氨氯地平阿托伐他汀钙片治疗,参照组予以苯磺酸氨氯地平治疗,比较两组患者的血压控制效果及血脂指标.结果 实验组患者的收缩压、舒张压下降程度明显优于参照组,实验组的TC、TG、LDL-C、HDL-C等血脂指标改善程度优于参照组,均 P〈0.05.结论 为合并冠心病的高血压患者采用氨氯地平阿托伐他汀钙片治疗,可有效控制患者血压值,同时还可改善其血脂指标,具有较高的临床推广价值.
Objective In this paper,the effect of amlodipine besylate and atorvastatin calcium tablets treatment of hypertension and coronary heart diseasewere discussed.Methods Our hospital treated 88 cases of hypertension in almost one year merger in pa-tients with coronary heart disease,according to the draw method is divided into experimental group (n=44)and control group (n=44),the experimental group were treated by amlodipine atorvastatin calcium treatment,control group to benzene sulfonic acid amlo-dipine treatment,compared two groups of patients with blood pressure control effect and blood lipids index.Results The patients with systolic pressure,diastolic blood pressure decreased significantly better than the control group,experimental group of TC,TG, LDL,HDL-C-C improved blood lipid indexes such as superior to control group,P〈0.05).Conclusion In order to merge coronary heart disease (CHD)patients with high blood pressure with amlodipine atorvastatin calcium treatment,patients can effectively con-trol the blood pressure value,also can improve the blood lipid index,has high clinical value.
出处
《检验医学与临床》
CAS
2017年第A02期108-110,共3页
Laboratory Medicine and Clinic
关键词
氨氯地平阿托伐他汀钙片
高血压
冠心病
效果分析
amlodipine besylate and atorvastatin calcium tablets
hypertension
coronary heart disease (CHI))
effect analysis